作者: Naoto Hata , Toru Nishikawa , Asami Umino , Kiyohisa Takahashi
DOI: 10.1016/0304-3940(90)90178-C
关键词: Endocrinology 、 Neuroscience 、 Antagonist 、 Inhibitory postsynaptic potential 、 NMDA receptor 、 Internal medicine 、 Dopamine 、 Dopaminergic 、 Competitive antagonist 、 3,4-Dihydroxyphenylacetic acid 、 Chemistry 、 Receptor 、 General Neuroscience
摘要: Abstract Bilateral infusion of dl -2-amino-5-phosphonovalerate ( -APV) (which is a competitive antagonist for N- methyl- d -aspartate (NMDA) receptor) into the medial frontal cortex conscious rats increased amount 3,4-dihydroxyphenylacetic acid (DOPAC) and DOPAC/dopamine (DA) ratio in cortical area. Moreover, intra-prefrontal injection -APV, -2-amino-7-phosphonoheptanoate 3-[(±)-2-carboxypiperazin-4-yl]-propyl-1-phosphonate are selective NMDA receptor antagonists), but not l -isomer APV γ-glutamyl-aminomethyl sulphonate (a relative non-NMDA receptors), facilitated prefrontal DA utilization NMDA-reversible manner. These findings suggest that NMDA-type excitatory amino receptors may be involved tonic inhibitory regulation dopaminergic transmission vivo.